Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02484950 · ClinicalTrials.gov registry record · NA
Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02484950 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 62 participants.
The verdict
NCT02484950, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The primary objective of this study is to compare the clinical outcomes of arthroscopic rotator cuff repair with and without augmentation of mesenchymal stem cells (MSCs). Mesenchymal stem cells promote tissue regeneration by differentiating into adult cell lines and by supplying growth factors to their implanted environment. They have been shown to be effective in improving both overall healing and tendon integrity in rotator cuff repair. This study will follow 100 patients in the United States and track their clinical outcomes for at least one year post-operatively.
Interventions
- BIOLOGICAL Mesenchymal stem cell augmentation in rotator cuff repair
- PROCEDURE Standard arthroscopic rotator cuff repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-11-15 |
| Est. Completion | 2024-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02484950
The ClinicalTrials.gov registry entry for NCT02484950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mesenchymal stem cell augmentation in rotator cuff repair is the first listed.
NCT02484950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02484950 about?
NCT02484950 is a clinical study titled "Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair". The primary objective of this study is to compare the clinical outcomes of arthroscopic rotator cuff repair with and without augmentation of mesenchymal stem cells (MSCs). Mesenchymal stem cells promote tissue regeneration by differentiating into adult cell lines and by supplying growth factors to t...
What is the current status of trial NCT02484950?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-11-15. Estimated completion is 2024-06-27.
What interventions are being tested in trial NCT02484950?
The interventions under investigation include: Mesenchymal stem cell augmentation in rotator cuff repair (BIOLOGICAL), Standard arthroscopic rotator cuff repair (PROCEDURE).
Who is sponsoring clinical trial NCT02484950?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.